期刊名
Cancer Medicine

CANCER MED-US

ISSN / eISSN
2045-7634 / 2045-7634
目标和范围
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations

Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.

Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.

Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.


Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
研究方向

肿瘤学

CiteScore
8.10 查看趋势图
CiteScore 学科排名
类别 分区 排名
Medicine - Radiology, Nuclear Medicine and Imaging Q1 #40/312
Medicine - Oncology Q1 #75/366
Medicine - Cancer Research Q2 #72/214
Web of Science 核心合集
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
ONCOLOGY - SCIE Q2
H-index
34
出版国家或地区
UNITED STATES
出版商
John Wiley and Sons Ltd
年文章数
1015
Open Access
YES
通讯方式
111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
What you have is nothing. I submitted in March, and it has been 10 months already. It is still under review. I have urged them countless times, but they just ignore me. Well, I don't have the time to submit to other magazines either. Let's see who can outlast whom. I hope to challenge the conventional understanding.
2021-01-29
Submitted at the end of the year, pending editor for two months, and then pending decision for another month. The reviewers didn't provide any feedback, and it took three months before they finally informed me of the rejection.
2022-03-14

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started